Gillian L Hirst

29PUBLICATIONS
146CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Apr 22, 2026
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

|Dec 09, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf

|Sep 04, 2025
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.

Emmanuel F Petricoin, Denise M Wolf, Christina Yau

|Jul 17, 2025
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer.

Justin Balko, Xiaopeng Sun, Ann Hanna

|Jul 02, 2025
Insights from a multi-institutional registry show duration of endocrine treatment for DCIS impacts second events.

Thomas J O'Keefe, Christina Yau, Emma Iaconetti

|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Denise M Wolf, Christina Yau, Michael Campbell

Pageof 5

Frequent Collaborators

22 joint publications

Laura J Esserman

18 joint publications

Laura Van't Veer

15 joint publications

Lamorna Brown-Swigart

11 joint publications

Christina Yau